We are live on ! Find out more
IMVT icon

Immunovant
IMVT

87 hedge funds and large institutions have $696M invested in Immunovant in 2020 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 29 increasing their positions, 11 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

259% more capital invested

Capital invested by funds: $194M → $696M (+$502M)

164% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 11

118% more funds holding

Funds holding: 40 → 87 (+47)

20.02% more ownership

Funds ownership: 23.21% → 43.23% (+20%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
87
Holders Change
+47
Holders Change %
+117.5%
% of All Funds
1.78%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
47
Increased
29
Reduced
11
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$36.2M
2
BlackRock
BlackRock
New York
+$30M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$28.8M
4
PC
Polar Capital
United Kingdom
+$28.3M
5
RI
RTW Investments
New York
+$27.7M

Top Sellers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
-$12M
2
MP
Mangrove Partners
Connecticut
-$9.46M
3
GTC
Ghost Tree Capital
New York
-$3.96M
4
WP
Woodline Partners
California
-$2.02M
5
BFM
Boothbay Fund Management
New York
-$1.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
51
Renaissance Technologies
New York
$884K +$778K +36,300 New
BFM
52
Boothbay Fund Management
New York
$865K -$1.8M -84,097 -70%
SSA
53
Schonfeld Strategic Advisors
New York
$837K +$737K +34,400 New
California State Teachers Retirement System (CalSTRS)
54
California State Teachers Retirement System (CalSTRS)
California
$702K +$617K +28,814 New
Jane Street
55
Jane Street
New York
$640K +$307K +14,331 +120%
HSBC Holdings
56
HSBC Holdings
United Kingdom
$615K -$74.3K -3,469 -12%
RhumbLine Advisers
57
RhumbLine Advisers
Massachusetts
$558K +$491K +22,901 New
New York State Common Retirement Fund
58
New York State Common Retirement Fund
New York
$426K +$375K +17,500 New
QSS
59
Quantitative Systematic Strategies
Florida
$416K +$33.5K +1,561 +10%
AC
60
Athanor Capital
New York
$398K +$350K +16,328 New
JP Morgan Chase
61
JP Morgan Chase
New York
$392K +$282K +13,169 +453%
CS
62
Credit Suisse
Switzerland
$325K +$287K +13,378 New
Citigroup
63
Citigroup
New York
$318K +$245K +11,452 +703%
EP
64
Eversept Partners
New York
$299K -$1.38M -64,600 -84%
Bank of America
65
Bank of America
North Carolina
$292K +$76.8K +3,585 +43%
AIG
66
American International Group
New York
$285K +$250K +11,688 New
Manulife (Manufacturers Life Insurance)
67
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$283K +$238K +11,117 New
SG Americas Securities
68
SG Americas Securities
New York
$254K +$223K +10,421 New
MIM
69
MetLife Investment Management
New Jersey
$230K +$202K +9,447 New
Two Sigma Investments
70
Two Sigma Investments
New York
$223K +$196K +9,147 New
UBS AM
71
UBS AM
Illinois
$217K +$191K +8,900 New
Morgan Stanley
72
Morgan Stanley
New York
$169K -$284K -13,233 -66%
UBS Group
73
UBS Group
Switzerland
$169K +$98.5K +4,598 +195%
MLICM
74
Metropolitan Life Insurance Company (MetLife)
New York
$159K +$140K +6,524 New
Fifth Third Bancorp
75
Fifth Third Bancorp
Ohio
$136K +$120K +5,587 New
1 2
3
4

IMVT Hedge Fund Activity: Q2 2020 in Review

87 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Immunovant (IMVT) for Q2 2020, worth a combined $696M — up 259% from $194M a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new IMVT positions and 0 closed out — a net gain of 47 holders — while 29 added to existing stakes and 11 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $36.2M. The largest seller was Ikarian Capital, cutting an estimated $12M.

  • 87 institutional investors held Immunovant (IMVT) as of Q2 2020, up from 40 in Q1 2020.
  • Funds reported $696M of Immunovant stock for Q2 2020, up 259% quarter-over-quarter.
  • 47 funds opened new Immunovant positions in Q2 2020 and 0 closed out, a net change of +47 holders.
  • The largest Immunovant buyer in Q2 2020 was Vanguard Group, an estimated $36.2M added.
  • The largest Immunovant seller in Q2 2020 was Ikarian Capital, an estimated $12M sold.

Based on aggregated 13F filings for Q2 2020.